Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Current Topics in Microbiology and Immunology|June 3, 2010
PI3K as a target for therapy in haematological malignanciesAsim KhwajaBritish Journal of Haematology|July 11, 2006
The role of Janus kinases in haemopoiesis and haematological malignancyAsim KhwajaCancer Cell|March 22, 2014
PI3Kδ inhibition hits a sensitive spot in B cell malignanciesBart Vanhaesebroeck, Asim KhwajaJournal of the Saudi Heart Association|April 30, 2019
Thyrocervical trunk perforation: A rare vascular complication during cardiac intervention through right radial approach: A case report and literature reviewMasood Ayyub Ghori, Abdulmajeed Al Zubaidi, Asim KhwajaCancer Research|January 30, 2009
Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiationClotilde Billottet, Lalita Banerjee, Bart Vanhaesebroeck, et al.The Journal of Biological Chemistry|December 12, 2002
The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinasesLouise Tatton, Gary M Morley, Rajesh Chopra, et al.British Journal of Haematology|March 5, 2003
Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitorsTim C P Somervaille, David C Linch, Asim KhwajaBritish Journal of Haematology|September 8, 2006
Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cellsVictoria L Grandage, Tamara Everington, David C Linch, et al.Oncogene|March 1, 2005
Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemiaMaria Simon, Victoria L Grandage, David C Linch, et al.Blood|April 9, 2004
Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cellsIra Jakupovic, Victoria L Grandage, David C Linch, et al.Pageof 16